Delivery Order SPE2DE24DA017-SPE2D626F64B5
- Not listed
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System on November 25, 2025, with a completion date of December 1, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $51,760.94 for the Arthrex ACP Double Syringe System on November 18, 2025, with an ultimate completion date of November 21, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for providing medical...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,600.00 for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions was awarded on September 23, 2025, with an ultimate completion date of September 26, 2025. The contract was issued without a set-aside designation, reflecting Arthrex's strong competitive position in the federal medical...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices based in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System, with an ultimate completion date of December 5, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc. was awarded a $4,950 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the Arthrex ACP Double Syringe System, with an ultimate completion date of July 24, 2025. The award represents a non-set-aside contract and is being performed at Arthrex's Naples, Florida location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order on July 29, 2025, valued at $1,650.00 for the Arthrex ACP Double Syringe System. The contract, which is not set aside for any specific business type, represents a fixed-price delivery with economic price adjustment provisions and has an ultimate completion date of August 1, 2025. The award falls under the Defense Logistics Agency's Medical Supply Chain, a defense agency function...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $4,356.00 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 24, 2025, and represents a specific task order issued under Arthrex's larger indefinite delivery contract (SPE2DE24D0020) with the Defense...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F64B5Delivery Order
Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $1,650 for the Arthrex ACP Double Syringe System, with an ultimate completion date of January 14, 2026. The award was issued on December 30, 2025, under a fixed-price contract with economic price adjustment terms. There is no set-aside designation associated with this procurement. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency supporting orthopedic medical supply requirements for federal healthcare systems. This delivery order is issued under Arthrex's single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, which carries a total value of $471,048,172.66 and runs through September 1, 2029. As a leading manufacturer of minimally invasive orthopedic medical technologies and surgical instruments, Arthrex serves as the prime contractor with no subcontractors noted, providing orthopedic implants, surgical instruments, and biologics directly to Department of Veterans Affairs medical centers and Department of Defense healthcare facilities. The ACP Double Syringe System represents one of numerous product offerings delivered through this comprehensive master contract vehicle to support the orthopedic surgical needs of military personnel and veterans nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/29/25 |